Company news
Corvus Pharmaceuticals, Inc. news in 2022
Corvus Pharmaceuticals, Inc.'s news releases, calls and decks from 2022, newest first.
Corvus Pharmaceuticals to Host Investor Conference Call and Webcast on December 12, 2022
December 4, 2022
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results
November 2, 2022
Corvus Pharmaceuticals Announces Initiation of Phase 1b/2 Clinical Trial of Ciforadenant as Potential First Line Treatment for Patients with Renal Cell Cancer
October 24, 2022
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Received IND Approval for Phase 1/1b Clinical Trial of Mupadolimab (Anti-CD73) in China
September 25, 2022
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results
August 7, 2022
Corvus Pharmaceuticals Appoints Dr. James Rosenbaum Senior Vice President of Research
July 20, 2022
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results
May 4, 2022
Corvus Pharmaceuticals to Host R&D Symposium on May 10, 2022 in New York
April 25, 2022
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
March 9, 2022
Corvus Pharmaceuticals to Provide Business Update and Report Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022
March 2, 2022
Corvus Pharmaceuticals Announces Partner Angel Pharmaceuticals Initiated Phase 1/1b Clinical Trial of ITK Inhibitor CPI-818 in China
January 12, 2022
Decks in 2022
- Technical Presentation (2022)
Technical · 15 slides · 2022